Hatch-Waxman Authors To Debate Generic Drug Issues At Audio Conference
This article was originally published in The Tan Sheet
The authors of the 1984 Drug Price Competition & Patent Term Restoration Act will discuss the challenges facing generic drug competitors during a Drug & Device Dialogue audio conference Oct. 6-7
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC